Yahsho
4 minutes ago
⚠️ A long-acting leronlimab update by March 10-20, 2025, is the call. ⚠️
It's rooted in SEC R&D, PR breadcrumbs, employee shifts, and a Gates-esque global health hook.
I went deep, every (10-Q, 10-K), PRs (2024-2025), Linkedin, and beyond flipping every stone. It's not